Shanghai Tchuquen Biotechnology Co., Ltd. was established in 2013. It is a biological consumables supplier focusing on the research and development and production of cell culture consumables. It has applied for multiple patents and won multiple awards. The company has a production workshop that meets GMP requirements, and the multilayer cellcarrier produced are internationally leading and occupy the main domestic market share in China. It has been used for producing rabies vaccines, polio vaccines, influenza vaccines, etc. In recent years, it has been expanded and applied in the field of cell therapy and stem cell culture, and has achieved good results. Currently, it is mainly effectively used in the following cells culture: VERO, CHO, BHK, MDCK, ST, MARC-5, SF9, HEK293, 123A and primary cells